SRTA

Strata Critical Medical, Inc.

Services-Health Services · SIC 8000CIK 1779128Held by 4 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:X LINKEDIN EMAIL

Revenue FY2025

$197.0M

Net Income FY2025

$41.0M

EPS (Basic, as reported)

$0.50

Net Margin FY2025

21.0%

ROE FY2025

14.8%

Total Equity

$279.0M

Shares Out

88M

Business description

Strata Critical Medical, Inc. — Services-Health Services. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2019–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions

default rows · click any row to chart itRevenue: 31 → 197 +36.1% CAGR

Fiscal yearFY2019FY2020⚑FY2021⚑FY2022FY2023FY2024FY2025

Revenue312351146225249197

Cost of revenue(26)(21)(40)(124)(183)(190)(156)

Gross profit—————3041

Selling, general & administrative—————(51)(61)

Selling & marketing(5)(3)(3)(8)(10)(8)—

General & administrative(10)(9)(30)(63)(95)(82)—

Total operating expenses(43)(1)(25)(37)(33)(52)(63)

Operating income(12)(1)(24)(54)(68)(34)(22)

Other income (expense), net10(20)251162

Pre-tax income(11)0(44)(28)(58)(28)(20)

Income tax expense00(4)(1)(1)00

Net income2(10)(40)(27)(56)(27)41

EPS — basic($0.43)($0.40)($0.93)($0.38)($0.76)($0.35)$0.50

EPS — diluted($0.43)($0.40)($0.93)($0.38)($0.76)($0.35)$0.50

Shares outstanding — basic (M)25254371747782

Shares outstanding — diluted (M)25254371747782

⚑ Weighted-average shares changed ×1.72 between FY2020 and FY2021 — a large issuance or reduction. Per-share figures on either side are as reported and not adjusted.
⚑ Weighted-average shares changed ×1.65 between FY2021 and FY2022 — a large issuance or reduction. Per-share figures on either side are as reported and not adjusted.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.